EFFECTOR Trademark

Trademark Overview

On Thursday, December 15, 2016, a trademark application was filed for EFFECTOR with the United States Patent and Trademark Office. The USPTO has given the EFFECTOR trademark a serial number of 87270238. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Tuesday, March 5, 2024. This trademark is owned by eFFECTOR Therapeutics, Inc.. The EFFECTOR trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

medical research; providing medical testing services and information in the field of cancer research and disease classification; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; pharmaceutical research and development
effector

General Information

Serial Number87270238
Word MarkEFFECTOR
Filing DateThursday, December 15, 2016
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateTuesday, March 5, 2024
Registration Number5404524
Registration DateTuesday, February 20, 2018
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 5, 2017

Trademark Statements

Goods and Servicesmedical research; providing medical testing services and information in the field of cancer research and disease classification; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; pharmaceutical research and development

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, December 21, 2016
Primary Code042
First Use Anywhere DateTuesday, July 31, 2012
First Use In Commerce DateTuesday, July 31, 2012

Trademark Owner History

Party NameeFFECTOR Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSolana Beach, CA 92075
Party NameeFFECTOR Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121
Party NameeFFECTOR Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Trademark Events

Event DateEvent Description
Tuesday, March 5, 2024NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Tuesday, March 5, 2024REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Tuesday, March 5, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, September 13, 2023TEAS SECTION 8 & 15 RECEIVED
Monday, February 20, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, July 20, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, July 20, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, July 20, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, January 22, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, January 22, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, February 20, 2018REGISTERED-PRINCIPAL REGISTER
Tuesday, December 5, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 5, 2017PUBLISHED FOR OPPOSITION
Wednesday, November 15, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, October 20, 2017ASSIGNED TO LIE
Saturday, October 7, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, September 15, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, September 13, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, September 13, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, September 13, 2017TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, March 17, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, March 17, 2017NON-FINAL ACTION E-MAILED
Friday, March 17, 2017NON-FINAL ACTION WRITTEN
Thursday, March 16, 2017ASSIGNED TO EXAMINER
Wednesday, December 21, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, December 19, 2016NEW APPLICATION ENTERED

Related Keywords

effector research medical field providing information clinical trials pharmaceutical development pharmaceuticals